Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Evans, D. A., Funkenstein, H. H., Albert, M. S., Scherr, P. A., Cook, N. R., Chown, M. J., Hebert, L. E., Hennekens, C. H., and Taylor, J. O., 1989, Prevalence of Alzheimer’s disease in a community population of older persons. Higher than previously reported, JAMA 262:2551–2556.
Brookmeyer, R., Gray, S., and Kawas, C., 1998, Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset, Am. J. Public Health 88:1337–1342.
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E. M., 1984, Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease, Neurology 34:939–944.
Wade, J. P., Mirsen, T. R., Hachinski, V. C., Fisman, M., Lau, C., and Merskey, H., 1987, The clinical diagnosis of Alzheimer’s disease, Arch. Neurol. 44:24–29.
Lee, M. K., Slunt, H. H., Martin, L. J., Thinakaran, G., Kim, G., Gandy, S. E., Seeger, M., Koo, E., Price, D. L., and Sisodia, S. S. (1996). Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues, J. Neurosci. 16:7513–7525.
Goate, A., Chartier-Harlin, M. C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., 1991, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease, Nature 349:704–706.
Levy-Lahad, E., Wijsman, E. M., Nemens, E., Anderson, L., Goddard, K. A., Weber, J. L., Bird, T. D., and Schellenberg, G. D., 1995, A familial Alzheimer’s disease locus on chromosome 1, Science 269:970–973.
Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., and et al., 1995, Familial Alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer’s disease type 3 gene, Nature 376:775–778.
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al., 1995, Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease, Nature 375:754–760.
Selkoe, D. J., Podlisny, M. B., Joachim, C. L., Vickers, E. A., Lee, G., Fritz, L. C., and Oltersdorf, T., 1988, Beta-amyloid precursor protein of Alzheimer disease occurs as 110-to 135-kilodalton membrane-associated proteins in neural and nonneural tissues, Proc. Natl. Acad. Sci. U.S.A. 85:7341–7345.
Schellenberg, G. D., 1995, Genetic dissection of Alzheimer disease, a heterogeneous disorder, Proc. Natl. Acad. Sci. U.S.A. 92:8552–8559.
Corder, E. H., Saunders, A. M., Strittmatter, W.J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., and Pericak-Vance, M. A., 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families, Science 261:921–923.
de Knijff, P., van den Maagdenberg, A. M., Frants, R. R., and Havekes, L. M., 1994, Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels, Hum. Mutat. 4:178–194.
Roses, A. D., 1996, Apolipoprotein E alleles as risk factors in Alzheimer’s disease, Annu. Rev. Med. 47:387–400.
Bergem, A. L., 1994, Heredity in dementia of the Alzheimer type, Clin. Genet. 46(1 Spec No):144–1449.
Schaefer, E.J., and Ordovas, J. M., 1986, Metabolism of apolipoproteins A-I, A-II, andA-IV, Methods Enzymol. 129:420–443.
Hofman, A., Ott, A., et al., 1997, Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam Study, Lancet 349:151–154.
Itzhaki, R.F., Lin, W.R., Shang, D., Wilcock, G. K., Faragher, B., and Jamieson, G. A., 1997, Herpes simplex virus type 1 in brain and risk of Alzheimer’s disease, Lancet 349:241–244. [see comments]
Miklossy, J., 1993, Alzheimer’s disease — a spirochetosis? Neuroreport 4:841–848.
Balin, B. J., Gerard, H. C., Arking, E. J., Appelt, D. M., Branigan, P. J., Abrams, J. T., Whittum-Hudson, J. A., and Hudson, A. P., 1998, Identification and localization of Chlamydia pneumoniae in the Alzheimer’s brain, Med. Microbiol. Immunol. (Berl) 187:23–42.
Schumacher, H. R., Jr., Gerard, H. C., Arayssi, T. K., Pando, J. A., Branigan, P. J., Saaibi, D. L., and Hudson, A. P., 1999, Lower prevalence of Chlamydia pneumoniae DNA. compared with Chlamydia trachomatis DNA in synovial tissue of arthritis patients, Arthritis Rheum. 42:1889–1893.
Gerard, H. C., Wang, G. F., Balin, B. J., Schumacher, H. R., and Hudson, A. P., 1999, Frequency of apolipoprotein E (APOE) allele types in patients with Chlamydia-associated arthritis and other arthritides, Microb. Pathog. 26:35–43.
Mahony, J.B., Woulfe, J., Munoz, D., Browning, D., Chong, S., Smieja, M., 2000a, Chlamydia pneumoniae in the Alzheimer’s brain—Is DNA detection hampered by low copy number? Paper presented at Fourth Meeting of the European Society for Chlamydia Research, Helsinki, Finland.
Mahony, J. B., Woulfe, J., Munoz, D., Browning, D., Chong, S., Smieja, M., 2000b, Identification of Chlamydiae pneumoniae in the Alzheimer’s brain. Paper presented at World Alzheimer Congress 2000 Proceedings.
Ossewaarde, J. M., Gielis-Proper, S. K., Meijer, A., Roholl, P.J. M., 2000, Chlamydiapneu-moniae antigens are present in the brains of Alzheimer patients, but not in the brains of patients with other dementias, Paper presented at Fourth Meeting of the European Society for Chlamydia Research, Helsinki, Finland.
Nochlin, D., Shaw, C. M., Campbell, L. A., and Kuo, C. C., 1999, Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer’s disease, Neurology 53:1888.
Gieffers, J., Reusche, E., Solbach, W., and Maass, M., 2000, Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer’s disease patients, J. Clin. Microbiol. 38:881–882.
Ring, R. H., and Lyons, J. M., 2000, Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer’sbrain, J. Clin. Microbiol. 38:2591–2594.
Taylor, G. S., Vipond, I. B., Paul, I. D., Matthews, S., Wilcock, G. K., and Caul, E. O., 2002, Failure to correlate C. pneumoniae with late onset Alzheimer’s disease, Neurology 59:142–143.
Grayston, J. T., Campbell, L. A., Kuo, C. C., Mordhorst, C. H., Saikku, P., Thom, D. H., and Wang, S. P., 1990, A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR, J. Infect. Dis. 161:618–625.
Hudson, A. P., Gerard, H. C., Whittum-Hudson, J. A., Appelt, D. M., and Balin, B.J., 2000, Chlamydia pneumoniae, APOE genotype, and Alzheimer’s disease, in: Chlamydia pneumoniae and Chronic Disease (J. L’age-Stehr, ed.), Springer-Verlag, New York, pp. 121–136.
MacIntyre, A., Abramov, R., Hammond, C. J., Hudson, A. P., Arking, E. J., Little, C. S., Appelt, D. M., Balin, B. J., 2003, Chlamydia pneumoniae infection of human brain endothelial cells and monocytes promotes the transmigration of monocytes through an in vitro blood brain barrier, J. Neurosci. Res., 71:740–750.
Airenne, S., Surcel, H. M., Alakarppa, H., Laitinen, K., Paavonen, J., Saikku, P., and Laurila, A., 1999, Chlamydia pneumoniae infection in human monocytes, Infect. Immun. 67:1445–1449. [published erratum appears in Infect. Immun. (1999) 67:6716]
Boman, J., Soderberg, S., Forsberg, J., Birgander, L. S., Allard, A., Persson, K., Jidell, E., Kumlin, U., Juto, P., Waldenstrom, A., and Wadell, G., 1998, High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors, J. Infect. Dis. 178:274–277.
MacIntyre, A., Hammond, C. J., Little, C. S., Appelt, D. M., and Balin, B. J., 2002, Chlamydia pneumoniae infection alters the junctional complex proteins of human brain microvascular endothelial cells, FEMS Microbiol. Lett. 217:167–172.
Hyman, B. T., Van Hoesen, G. W., Kromer, L. J., and Damasio, A. R., 1986, Perforant pathway changes and the memory impairment of Alzheimer’s disease, Ann. Neurol. 20:472–481.
Rasmussen, S. J., Eckmann, L., Quayle, A. J., Shen, L., Zhang, Y. X., Anderson, D. J., Fierer, J., Stephens, R. S., and Kagnoff, M. F., 1997, Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis, J. Clin. Invest. 99:77–87.
Simon, A. K., Seipelt, E., Wu, P., Wenzel, B., Braun, J., and Sieper, J., 1993, Analysis of cytokine profiles in synovial T cell clones from chlamydial reactive arthritis patients: Predominance of the Th1 subset, Clin. Exp. Immunol. 94:122–126.
Hauss-Wegrzyniak, B., Lukovic, L., Bigaud, M., and Stoeckel, M. E., 1998, Brain inflammatory response induced by intracerebroventricular infusion of lipopolysaccharide: An immunohistochemicalstudy, Brain Res. 794:211–224.
Lue, L. F., Brachova, L., Civin, W. H., and Rogers, J., 1996, Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer’s disease neurodegeneration, J. Neuropathol. Exp. Neurol. 55:1083–1088.
Breitner, J. C., 1996, The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer’s disease, Annu. Rev. Med. 47:401–411.
Wood, P. L., 1998, Role of CNS macrophages in neurodegeneration, in: Neuroinflammation Mechanisms and Management (P. L. Wood, ed.), Humana Press, Totowa, NJ, pp. 1–59.
Boven, L. A., Middel, J., Breij, E. C., Schotte, D., Verhoef, J., Soderland, C., and Nottet, H. S., 2000, Interactions between HIV-infected monocyte-derived macrophages and human brain microvascular endothelial cells result in increased expression of CC chemokines, J. Neurovirol. 6:382–389.
Hu, J., and Van Eldik, L. J., 1999, Glial-derived proteins activate cultured astrocytes and enhance beta amyloid-induced glial activation, Brain Res. 842:46–54.
Simpson, J. E., Newcombe, J., Cuzner, M. L., and Woodroofe, M. N., 1998, Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions, J. Neuroimmunol. 84:238–249.
Weiss, J. M., Downie, S. A., Lyman, W. D., and Berman, J. W., 1998, Astrocyte-derived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of the human blood-brain barrier, J. Immunol. 161:6896–6903.
Persidsky, Y., 1999, Model systems for studies of leukocyte migration across the blood-brain barrier, J. Neurovirol. 5:579–590.
Gieffers, J., Pohl, D., Treib, J., Dittmann, R., Stephan, C., Klotz, K., Hanefeld, F., Solbach, W., Haass, A., and Maass, M., 2001, Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis, Ann. Neurol. 49:585–589.
Esiri, M. M., and Wilcock, G. K., 1984, The olfactory bulbs in Alzheimer’s disease, J. Neurol. Neurosurg. Psychiatry 47:56–60.
Little, C. S., Hammond, C. J., MacIntyre, A., Balin, B. J., and Appelt, D. M., 2004, Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice, Neurobiol. Aging 25:419–429.
D’Andrea, M. R., Nagele, R. G., Wang, H. Y., and Lee, D. H., 2002, Consistent immunohistochemical detection of intracellular beta-amyloid42 in pyramidal neurons of Alzheimer’s disease entorhinal cortex, Neurosci. Lett. 333:163–166.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science + Business Media, Inc.
About this chapter
Cite this chapter
Balin, B.J., Hammond, C.J., Scott Little, C., MacIntyre, A., Appelt, D.M. (2005). Chlamydia pneumoniae in the Pathogenesis of Alzheimer’s Disease. In: Friedman, H., Yamamoto, Y., Bendinelli, M. (eds) Chlamydia pneumoniae Infection and Disease. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/0-306-48741-1_15
Download citation
DOI: https://doi.org/10.1007/0-306-48741-1_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-48487-2
Online ISBN: 978-0-306-48741-5
eBook Packages: Springer Book Archive